1.Current status and future of the military hospital information system
Bulletin of The Academy of Military Medical Sciences 2001;25(2):147-151
Hospital information system is a computer system network which meets the need of modernization of hospital information management. In recent years the development of information technology such as computer technology,communication technology provides strong technology support for the development of hospital information system. The history, current status of the military hospital information system at home and abroad and future prospect of our military hospitals are reviewed.
2.The clinical progress of blood purification in treatment of paraquat poisoning
Guoqiang LI ; Liang SUN ; Yuming LI
China Medical Equipment 2014;(6):79-83
The high mortality of paraquat (PQ) poisonings is mainly due to the lack of effective treatments. The optimal method of extracorporeal removal of paraquat is often a matter of debate. Due to the lack of well-designed studies, we are often left with circumstantial evidence, and we must exercise our best clinical judgment as to whether extracorporeal paraquat removal is beneficial and if so, by what method. It is clear, however, that rapidity in paraquat removal is beneficial. Due to the urgent nature of treatment for paraquat poisoning, there may never be well-designed evidence-based studies to help guide us. In the meantime, we must continue to use less than ideal evidence and our own experience to guide our decision-making process. Most toxicologists recommend rapid initiation of charcoal haemoperfusion (CHP) to lower plasma PQ levels and to limit pulmonary and other organs uptake of PQ.
3.Clinical study on meropenem and imipenem/cilastatin in treatment of respiratory tract infections
Yuming SONG ; Jianjun ZHAO ; Lu SUN
Chinese Pharmaceutical Journal 2001;(2):128-129
OBJECTIVE To evaluate the availability and safety of a new carbapenem meropenem.METHODS The randomized study was conducted in 60 patients with respiratory tract infections.They were divided into two groups:meropenem or imipenem/cilastatin.RESULTS The cure rate,effective rate and bacterial clearance rate for meropenem were 80.0%,93.3%,92.3%,respectively and for those of imipenem/cilastatin were 76.7%,90.0% and 91.3%,respectively.The rate of adverse reactions for both meropenem/cilastatin was 3.3%.CONCLUSION Meropenem appeared to be a highly effective and safe agent in treatment of respiratory tract infections.Its efficacy and safety are similar to that of imipenem/cilastatin.
4.Study on Percutaneous Absorption and Synergistic Penetration Enhancement Effect of Aconitine,Ginsenoside Rg_1 and Tetrahydropalmatine
Qing ZHANG ; Yuming SUN ; Qing WANG
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(09):-
Objective To study percutaneous absorption kinetics and synergistic penetration enhancement of tetrahydropalmatine,aconitine and ginsenoside Rg1.Methods The in vitro intact and stripped skin permeation experiments were carried out by using Permcell KH-5P horizontal proliferation system.The percutaneous kinetic parameters of tetrahydropalmatine,aconitine and ginsenoside Rg1 were determined by HPLC,and the transdermal behaviors of the three active ingredients and interactions of combination were investigated.Result The cumulative amounts in 24 h of intact skin of tetrahydropalmatine,aconitine and ginsenoside Rg1 were 123.95,50.32,96.25(?10-10 cm2/s).The cumulative amounts in 24 h of stripped skin of them were 539.00,93.60,354.70(?10-10 cm2/s).The LogP were 1.66,0.66 and 0.57 respectively.Each component had cumulated amount permeated of improvement by 64%~293% in coexistence system of three active ingredients.Conclusion The combination of three active ingredients results in a synergistic enhancement effect on percutaneous absorption of every active ingredient,and it is shown that the maximal enhancement effect appears between aconitine and ginsenoside Rg1.
5.Analysis of the effect of omeprazole and tegaserod on non-erosive reflux disease
Yuming TANG ; Bin XU ; Jing SUN
Chinese Journal of Practical Internal Medicine 2006;0(13):-
0.05).Conclusion Omeprazole and Tegaserod improved the reflux symptoms of the NERD patients.Omeprazole improves abnormal acid exposure but not abnormal bile exposure.Tegaserod improved neither abnormal acid exposure nor abnormal bile exposure.
6.Researches on relative genes determing sensitivity to volatile anesthetics
Yunfei CAO ; Yuming SUN ; Weifeng YU ;
Academic Journal of Second Military Medical University 2001;0(09):-
The use of genetic approaches to probe relative genes that control sensitivity to volatile anesthetics in intact model has recently emerged as the powerful tools and strategies in dissecting mechanisms of anesthesia. Multiple model organisms such as yeast, nematodes, fruitflies and mammals are currently being exploited, and a number of sensitive genes have been screened, with some of them being cloned, located, and function identified. The emerging technologies are likely to provide further great advances for elucidating the specific anesthetic molecular sites.
7.Effects of different ratios of concentration and volume of bupivacaine and fentanyl on postoperative epidural analgesia
Yunfei CAO ; Yuming SUN ; Weifeng YU ;
Academic Journal of Second Military Medical University 2001;0(09):-
G1.(3)Among 5 groups,the highest incidences of nausea,vomiting and pruritis were observed in group G1 for about 24% 32%,but with no statistical difference compared with other groups.Conclusion: With equal doses of bupivacaine and fentanyl mixed,the concentration/volume ratios may affect the analgesic effects of postoperative epidural analgesia in patients with hepatectomy.
8.Effects of Recombinant Human Growth Hormone on Pathophysiology of Critically Ill Patients
Rongqing SUN ; Min FENG ; Yuming DU ;
Chinese Journal of Bases and Clinics in General Surgery 2003;0(04):-
Objective To investigate the role of recombinant human growth hormone (rhGH) in the treatment of patients with multiple organ dysfunction syndrome (MODS). Methods Thirty eight patients with MODS routinely treated with antibiotics and nutrition support were divided into two groups: the rhGH group and control group. The rhGH group was treated by subcutaneous injection of 5 U rhGH for two weeks. Results On the 7th day of treatment, the score of APACHE Ⅱ in the rhGH group was much higher than the control group, the levels of ALT, AST, BUN and Cre did not change much compared with the control group. The level of albumin in the rhGH group increased ( P
9.Development of a quality assurance system for drug-control institute
Wenming SUN ; Zhuoliang GU ; Yuming ZHANG
Chinese Medical Equipment Journal 2003;0(S1):-
Based on the requirements of quality assurance during drug control process,a quality assurance system is developed for drug control in the institute of drug and equipment control.The results show that the method developed in this paper is much suitable tothe process of drug control and can be applied tocontrolling the quality from the drug receiving tothe drug releasing.The quality assurance system guarantees that the detected data are achieved scientifically and efficiently.
10.Cerebral ischemic tolerance induced by 3-nitropropionic acid is associated with increased expression of erythropoietin in rats.
Hongcan, ZHU ; Shenggang, SUN ; Hongge, LI ; Yuming, XU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2006;26(4):440-3
To examine the changes in erythropoietin (Epo) protein and its mRNA expression in rat brain subjected to focal ischemia and possible mechanism of the preconditioning of mitochondrial toxin 3-nitropropionic acid (3-NPA), rats were administrated either vehicle or 3-NPA at a dose of 20 mg/kg, intraperitoneally (ip), 3 days prior to a 2-h middle cerebral artery occlusion followed by 24-h reperfusion. Infarct volumes were measured by using 2, 3, 5 triphenylte trazolinm chloride (TTC) staining, and Epo protein and its mRNA levels were assessed by immunohistochemistry and reverse transcriptase polymerase chain reaction (RT-PCR), respectively. Our results showed that after reperfusion, Epo was found to be expressed extensively in the rat brain. It was most apparent in the basal nuclei and hippocampus, and was, to some extent, present in cortex. Preconditioning with 3-NPA caused a reduction in infarct volume. The expression of both Epo protein and mRNA increased significantly in the different brain areas in the 3-NPA pretreated group as compared with the non-pretreated ischemia model group. These results suggested that preconditioning with low dose 3-NPA could induce ischemic tolerance and neuro-protective effects by increasing the Epo expression in the ischemic and ischemia-related areas.